Foxconn factory in China recognized for Fourth Industrial Revolution technologies

Taiwan's Foxconn Technology Group announced that a second of the company's factories, a factory based in Chengdu, C...

March 16, 2021 | Tuesday | News
Wugen inks deal with Alpha Biopharma for cancer cell therapies in Asia

Wugen Inc., a clinical-stage biotechnology company developing novel universal natural killer (NK) and T-cell therapies f...

March 10, 2021 | Wednesday | News
BWXT and GMS to launch Nuclear Medicine in Asia-Pacific Region

BWXT Medical Ltd. and Global Medical Solutions, Ltd. (GMS) have entered into a joint venture (JV) to manufacture and dis...

March 9, 2021 | Tuesday | News
Vetter Pharma establishes office in China

Germany based Vetter, one of the global leaders in prefilled drug-delivery systems, has announced the opening of a ...

March 8, 2021 | Monday | News
I Holland restructures the leadership team to strengthen operations

England's I Holland, leaders in the manufacture of tablet tooling for the pharmaceutical and nutraceutical markets, has ...

March 2, 2021 | Tuesday | News
WuXi Biologics unravels world's largest 36,000L biomanufacturing line 

  WuXi Biologics, a global company with leading open-access biologics technology platforms, today announced th...

February 9, 2021 | Tuesday | News
Antengene collaborates with WuXi Biologics, WuXi STA for ADC asset

Antengene Corporation Limited, a China based innovative biopharmaceutical company dedicated to discovering, developing a...

February 3, 2021 | Wednesday | News
Thermo Fisher Scientific to acquire Mesa Biotech for $450M

Thermo Fisher Scientific Inc., the world leader in serving science, on Jan 19, 2021 announced it has entered into a...

January 21, 2021 | Thursday | News
Innovent Out-license Biosimilar development and commercialization rights in Indonesia

China's Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes...

January 19, 2021 | Tuesday | News
Italian firm brings bacterial conjunctivitis drug to Asia

NTC, an international R&D-focused pharmaceutical company based in Italy, and Zhaoke (Hong Kong) Ophthalmology Pharma...

January 18, 2021 | Monday | News
Fujifilm injects $76M into manufacturing and innovation centre

Japanese firm FUJIFILM Corporation and the Center for Advanced Biological Innovation and Manufacturing (CABIM), have ann...

January 18, 2021 | Monday | News
Chugai Pharma conducts digital transformation for manufacturing function

Chugai Pharmaceutical Co., Ltd. on Jan 12, 2021, announced its digital transformation (DX) for manufacturing functi...

January 14, 2021 | Thursday | News
Jumpstart Cell & Gene Therapy Commercialization with SUT Learning

The FDA’s approvals of more cell and gene therapies (CGTs) are cause for celebration — but the marathon is n...

April 2, 2021 | Friday | Opinion
KSQ Therapeutics and Takeda to develop and market novel Immuno-Oncology therapies

KSQ Therapeutics, a biotechnology company using its proprietary CRISPRomics® discovery platform to systematically sc...

January 14, 2021 | Thursday | News
BeiGene inks deal with Novartis to jointly develop oncology drug

BeiGene, Ltd, a China based commercial-stage biotechnology company focused on developing and commercialising innovative ...

January 12, 2021 | Tuesday | News
Driving laboratory efficiency with Data Intelligence: Expert Opinion

Pharmaceutical companies are poised for significant growth within the Asia Pacific region, with projections estimated as...

December 1, 2020 | Tuesday | Regulatory
Antengene's integrated APAC platform to develop innovative oncology therapies

Antengene Corporation Limited, a clinical-stage biopharmaceutical company with integrated drug discovery, clinical devel...

November 24, 2020 | Tuesday | News
Thermo Fisher to establish new pharma services facility in China

Thermo Fisher Scientific Inc. has signed a joint venture agreement to establish a new pharma services facility in H...

November 6, 2020 | Friday | News